Drugs Made In America Acquisition Corp. (DMAAU)
NGM · Financial Services · Shell Companies
$11.32
+0.00%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$330.2M
Shares Outstanding
29.2M
Exchange
NGM
Currency
USD
About Drugs Made In America Acquisition Corp.
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -132K | -264K | -2.1M | -143K |
| Net Income | 2.3M | 2.2M | 213K | 2.0M |
Annual Financials
| Metric | 2025-12-31 |
|---|---|
| Revenue | 0.00 |
| Operating Income | -2.8M |
| Net Income | 5.9M |